Archive: 16/04/2018
Using pre-surgical anti-PD 1 therapy in melanoma patients can identify those most likely to benefit
Checkpoint inhibitors that block the protein PD-1 are used in melanoma patients after they've had surgery to remove their cancer, but not all patients benefit from the immunotherapy. Now a new study from the Abramson Cancer ...
Apr 16, 2018
Study finds relationship between PTEN loss, potential for immune response in BRCA 1/2-deficient ovarian cancer
The protein known as phosphatase and tensin homolog (PTEN) is frequently mutated or affected by cancer as tumors develop. Now a new study from the Basser Center for BRCA at the Abramson Cancer Center of the University of ...
Apr 16, 2018